elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q47318847-87186E45-0123-439D-AF97-8250A519E7EB
Q47318847-87186E45-0123-439D-AF97-8250A519E7EB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47318847-87186E45-0123-439D-AF97-8250A519E7EB
MEK inhibitors under development for treatment of non-small-cell lung cancer.
P2860
Q47318847-87186E45-0123-439D-AF97-8250A519E7EB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47318847-87186E45-0123-439D-AF97-8250A519E7EB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2598ef9412257aa8fcb7e0b869be84f610d82b6f
P2860
Drug response prediction by inferring pathway-response associations with kernelized Bayesian matrix factorization.